Taro Pharmaceutical Industries Earnings Date, Estimates & History (NYSE:TARO)

$73.60

-0.15 (-0.20 %)

(As of 02/25/2020 04:00 PM ET)

Add

Compare

Today's Range

$73.03

Now: $73.60▼

$74.00

50-Day Range

$72.50

MA: $79.89▼

$86.64

52-Week Range

$71.76

Now: $73.60▼

$109.42

Volume59,200 shs

Average Volume45,184 shs

Market Capitalization$2.82 billion

P/E Ratio11.39

Dividend YieldN/A

Beta0.6

Taro Pharmaceutical Industries (NYSE:TARO) Earnings Information

Taro Pharmaceutical Industries last announced its quarterly earnings results on February 3rd, 2020. The reported $1.76 EPS for the quarter, beating analysts' consensus estimates of $1.54 by $0.22. The firm earned $147.68 million during the quarter, compared to analyst estimates of $172 million. Taro Pharmaceutical Industries has generated $7.23 earnings per share over the last year and currently has a price-to-earnings ratio of 11.4. Taro Pharmaceutical Industries has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 27th, 2020 based off prior year's report dates.

Taro Pharmaceutical Industries Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Taro Pharmaceutical Industries (NYSE:TARO) Earnings Estimates

Current Year EPS Consensus Estimate: $6.47 EPS
Next Year EPS Consensus Estimate: $7.01 EPS

Taro Pharmaceutical Industries (NYSE TARO) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Reported EPS	GAAP EPS	Revenue Estimate	Actual Revenue	Conference Call
5/27/2020 (Estimated)
2/3/2020	Q3	$1.54	$1.76	$1.76	$172.00 million	$147.68 million	N/A
11/4/2019	Q2	$1.72	$1.46	$1.46	$168.60 million	$160.85 million	Transcript
8/8/2019	Q1	$1.96	$1.72	$1.72	$169.80 million	$161.30 million	N/A
5/22/2019	Q4	$2.26	$1.52	$1.52	$189.90 million	$179.92 million	Transcript
2/6/2019	Q3 2019	$1.95	$2.40	$2.40	$174.70 million	$176.38 million	N/A
11/5/2018	9/30/2018	$1.96	$1.60	$1.60	$167.40 million	$158.97 million	N/A
8/9/2018	6/30/2018	$2.33	$1.71	$1.71	$179.54 million	$154.62 million	N/A
5/17/2018	3/31/2018	$1.51	$2.17	$2.17	$166.59 million	$175.22 million	Transcript
2/7/2018	Q3 2018		$1.37	$2.29		$155.46 million	N/A
11/7/2017	Q2 2018		$1.30	$1.30		$169.92 million	N/A
8/8/2017	Q1 2018		$1.35	$1.35		$161.32 million	N/A
5/22/2017	Q4		$2.05	$2.05		$196.41 million	N/A
2/9/2017	Q3 2017		$3.42	$3.42		$220.40 million	N/A
11/8/2016	Q2 2017		$3.00	$3.00		$228.79 million	Listen
8/10/2016	Q1 2017		$2.59	$2.59	$215.30 million	$233.80 million	N/A
5/26/2016	Q4 2016		$2.68	$2.68		$265.07 million	Listen
2/10/2016	Q3 2016		$4.41	$4.41	$974.38 million	$258.30 million	N/A
11/3/2015	Q2 2016		$3.11	$3.11		$212.06 million	N/A
8/6/2015	Q1 2016		$2.42	$2.42	$1.01 billion	$215.30 million	N/A
5/26/2015	Q4 2015		$3.56	$3.56	$881.79 million	$244.18 million	Listen
2/10/2015	Q3 2015		$3.33	$3.33	$213.60 million	$237.70 million	N/A
11/9/2014	Q2 2015		$3.35	$3.35		$250.83 million	N/A
8/7/2014	Q1 2015		$0.98	$0.88		$130.23 million	N/A
5/27/2014	Q4 2014		$2.10	$2.10	$165.13 million	$187.20 million	N/A
2/10/2014	Q3 2014		$2.59	$2.59	$185.70 million	$213.60 million	N/A
11/12/2013	Q2 2014		$2.15	$2.15		$205.32 million	N/A
8/7/2013	Q1 2014		$1.32	$1.32	$159.15 million	$153.20 million	N/A
5/23/2013	Q4 2013		$1.45	$1.80	$145.00 million	$165.10 million	N/A
2/4/2013	Q3 2013		$1.98	$1.98			N/A
11/1/2012	Q213		$1.46		$138.25 million	$160.97 million	N/A
8/6/2012	Q1 2013		$1.41	$1.41			N/A
5/24/2012	Q4 2012		$1.06	$1.06			N/A
2/10/2012	Q3 2012		$1.42	$1.44			N/A
11/10/2011	Q2 2012		$1.31	$1.30			N/A
7/26/2011	Q1 2012		$0.81	$0.82			N/A
5/26/2011	Q4 2011		$0.58	$0.58			N/A
1/28/2011	Q3 2011		$0.11	$0.11			N/A
10/29/2010	Q2 2011		$0.46	$0.46			N/A
8/23/2010	Q1 2011		$0.46	$0.46			N/A
6/14/2010	Q4 2010		$0.25	$0.25			N/A
12/2/2009	Q2 2010		$0.24	$0.24			N/A
8/10/2009	Q1 2010		$0.31	$0.31			N/A
5/22/2009	Q4 2009		$0.27	$0.27			N/A
2/10/2009	Q3 2009		$0.65	$0.85			N/A
11/11/2008	Q2 2009		$0.31	$0.31			N/A

(Earnings results data provided by Zacks Investment Research)

This page was last updated on 2/25/2020 by MarketBeat.com Staff

Featured Article: How to execute a trade ex-dividend strategy?

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Taro Pharmaceutical Industries Earnings Date, Estimates & History (NYSE:TARO)

Adding

Adding

Adding Taro Pharmaceutical Industries Ltd.

Earnings

Taro Pharmaceutical Industries (NYSE:TARO) Earnings Information

Taro Pharmaceutical Industries Earnings Estimates and Actuals by Quarter

Taro Pharmaceutical Industries (NYSE:TARO) Earnings Estimates

Taro Pharmaceutical Industries (NYSE TARO) Earnings History by Quarter

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources